Vitiligo is an acquired depigmentary skin disorder due to the loss of cutaneous melanocytes or alteration in melanocyte function, affecting over 0.5% of the world population. The exact cause of melanocyte loss in non-segmental vitiligo is still debatable, but many observations have pointed to the main role of cellular immunity. Earlier evidence has shown that depigmenting vitiligo skin is accompanied by CD8+ T cytotoxic lymphocytes infiltrates at the dermal-epidermal junction. Dysregulation of Tregs may be one of the factors that can break tolerance to melanocyte self-antigens and contribute to the pathogenesis of vitiligo. The objectives of the present study were to provide evidence of the presence of a functional defect and decrease of pe...
International audienceVitiligo is the most common depigmenting disorder affecting 0.1%-2% of the pop...
International audienceVitiligo is the most common depigmenting disorder affecting 0.1%-2% of the pop...
International audienceVitiligo is the most common depigmenting disorder affecting 0.1%-2% of the pop...
Melanocyte-specific CD8+ cytotoxic T lymphocytes (CTLs) play a pivotal role in vitiligo-induced depi...
Melanocyte-specific CD8(+) cytotoxic T lymphocytes (CTLs) play a pivotal role in vitiligo-induced de...
Vitiligo, a depigmentary disorder, caused by the loss of melanocytes, affects approximately 1% of th...
In human vitiligo, cutaneous depigmentation involves cytotoxic activity of autoreactive T cells. It ...
---International audienceVitiligo is a chronic skin disease characterized by the appearance of zones...
Autoimmune depigmentation of the skin, vitiligo, afflicts a considerable number of people, yet no ef...
Accumulating studies have indicated immune-based destruction of melanocytes in both segmental vitili...
Accumulating studies have indicated immune-based destruction of melanocytes in both segmental vitili...
Vitiligo is a skin and hair disorder characterized by circumscribed depigmented lesions due to lack ...
Immunological alterations have been implicated in the etiopathogenesis of vitiligo. The aim of this ...
Vitiligo is an autoimmune condition characterized by loss of epidermal melanocytes. High frequencies...
International audienceVitiligo is the most common depigmenting disorder affecting 0.1%-2% of the pop...
International audienceVitiligo is the most common depigmenting disorder affecting 0.1%-2% of the pop...
International audienceVitiligo is the most common depigmenting disorder affecting 0.1%-2% of the pop...
International audienceVitiligo is the most common depigmenting disorder affecting 0.1%-2% of the pop...
Melanocyte-specific CD8+ cytotoxic T lymphocytes (CTLs) play a pivotal role in vitiligo-induced depi...
Melanocyte-specific CD8(+) cytotoxic T lymphocytes (CTLs) play a pivotal role in vitiligo-induced de...
Vitiligo, a depigmentary disorder, caused by the loss of melanocytes, affects approximately 1% of th...
In human vitiligo, cutaneous depigmentation involves cytotoxic activity of autoreactive T cells. It ...
---International audienceVitiligo is a chronic skin disease characterized by the appearance of zones...
Autoimmune depigmentation of the skin, vitiligo, afflicts a considerable number of people, yet no ef...
Accumulating studies have indicated immune-based destruction of melanocytes in both segmental vitili...
Accumulating studies have indicated immune-based destruction of melanocytes in both segmental vitili...
Vitiligo is a skin and hair disorder characterized by circumscribed depigmented lesions due to lack ...
Immunological alterations have been implicated in the etiopathogenesis of vitiligo. The aim of this ...
Vitiligo is an autoimmune condition characterized by loss of epidermal melanocytes. High frequencies...
International audienceVitiligo is the most common depigmenting disorder affecting 0.1%-2% of the pop...
International audienceVitiligo is the most common depigmenting disorder affecting 0.1%-2% of the pop...
International audienceVitiligo is the most common depigmenting disorder affecting 0.1%-2% of the pop...
International audienceVitiligo is the most common depigmenting disorder affecting 0.1%-2% of the pop...